Drug Profile
Research programme: pain therapeutic - BioMed Valley Discoveries
Alternative Names: BVD-MORLatest Information Update: 26 Feb 2016
Price :
$50
*
At a glance
- Originator BioMed Valley Discoveries
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 25 Feb 2016 Discontinued - Preclinical for Pain in USA (unspecified route)
- 15 Feb 2013 Preclinical trials in Pain in USA (unspecified route)